Atlas Antibodies has acquired 3 companies, including 3 in the last 5 years. A total of 2 acquisitions came from private equity firms.
Atlas Antibodies has acquired in 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).
Arsenalsgatan 8C,
Stockholm,
SE-103 32
Sweden,
www.atlasantibodies.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2021-07-01 |
evitria · Life Science
Zurich, Switzerland · www.evitria.com evitria is a biotechnology company specialized in protein expression. evitria AG offers custom monoclonal antibodies and comparable molecules as well as gene expression services. evitria has been conducting more than 40,000 transfections. Customers of evitria are typically renowned pharmaceutical and biotechnology companies as well as research institutions. The customers have a constant demand for specific proteins tailored to the respective research purposes they use evitria as a highly specialized outsourcing partner. evitria was founded in 2010 and is based in Zurich, Switzerland. |
- | Add-on Acquisition |
SHS Capital
PE
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
